osteolabs GmbH was successfully spun off from GEOMAR in 2018. The OsteoTest is able to make early statements about the occurrence of possible osteoporosis from a urine and/or blood sample. Osteoporosis affects many patients. The disease is caused by the breakdown of calcium in the bones and thus endangers the stability of the skeleton. The consequences are frequent bone fractures, which the OsteoTest can minimise or even prevent. The test procedure was recently awarded the EARTO Innovation Prize.